Transcat, Inc.

NASDAQ:TRNS

Industrial - Distribution

Industrials
$100.12 +2.19%

+$2.00 today

Market cap
$941.61M
Beta
0.70
P/E (TTM)
150.2
EPS (TTM)
$0.62
52W Low $50.23High $94.76

Volume 0.11M

Average 0.16M

TRNS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Transcat, Inc.NASDAQ: TRNS

Gross Margin · Q3 FY2026 · quarter ended Dec 2025

Gross margin widens to 34.1%

Gross margin was 34.1% in Q3 FY2026, up 2.8 pp from a year earlier. On a trailing-twelve-month basis it was 32.6%, up 0.0 pp year over year. Over 3 fiscal years it widened by 3.0 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
34.1%+1.6 pp QoQ
Last fiscal yearMar 2026
32.6%+0.5 pp YoY
LTMMar 2026
32.6%+0.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.8 pp——
1 year+0.5 pp——
3 years+3.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
32.6%
Year-over-year change
+0.5pp

Gross Margin vs competitors

How TRNS compares with its peers on the latest reported figures

  • TRNS's LTM Mar 2026 gross margin of 32.6% is the 9th highest of the 11 companies compared; the peer median is 46.6%.
  • Its year-over-year change of +0.0 pp is the 4th highest of 11, against a peer median of -0.6 pp.
  • Over three fiscal years its change of +3.0 pp compares with a peer median of +2.1 pp.
TRNS Competitors Peer median
Gross Margin for TRNS and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
BLFSBioLife Solutions, Inc.LTM Mar 202663.9% -19.5 pp+3.0 pp
MTDMettler-Toledo International Inc.LTM Jun 202658.4% -0.2 pp+2.2 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
LABStandard BioTools Inc.LTM Mar 202648.3% -1.2 pp+12.0 pp
QDELQuidelOrtho CorporationLTM Mar 202645.0% -2.0 pp-12.6 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
TKNOAlpha Teknova, Inc.LTM Mar 202633.3% +12.3 pp-9.0 pp
TRNSTranscat, Inc.LTM Mar 202632.6% +0.0 pp+3.0 pp
TICTIC Solutions, Inc.LTM Jun 202632.0% +9.8 pp+7.5 pp
UFPTUFP Technologies, Inc.LTM Jun 202628.5% -0.3 pp+2.8 pp
Peer median (excluding TRNS) 46.6%-0.6 pp+2.1 pp

Competitors are the stored peer set for TRNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue204.96M230.57M259.48M278.42M331.88M
Cost of Revenue146.52M162.21M175.68M188.97M223.57M
Gross Profit58.44M68.36M83.81M89.45M108.3M
Gross Margin28.5%29.6%32.3%32.1%32.6%
Research & Development00000
Selling, General & Admin44.3M52.11M64.03M71.58M95.04M
Operating Expenses44.3M52.11M64.03M71.58M95.04M
Depreciation & Amortization9.57M10.96M13.54M18.57M26.17M
EBITDA23.57M26.86M33.82M37.69M38.76M
EBITDA Margin11.5%11.6%13.0%13.5%11.7%
Operating Income14.14M16.25M19.78M17.87M13.26M
Operating Margin6.9%7.0%7.6%6.4%4.0%
Interest Income00808K825K0
Interest Expense810K2.42M1.84M798K5.27M
Other Income / Expenses(953K)(2.76M)(1.34M)452K(5.27M)
Income Before Tax13.19M13.49M18.44M18.33M7.99M
Pre-Tax Margin6.4%5.8%7.1%6.6%2.4%
Income Tax Expense1.81M2.8M4.79M3.81M2.61M
Net Income11.38M10.69M13.65M14.52M5.38M
Net Margin5.6%4.6%5.3%5.2%1.6%
EPS (Basic)1.521.421.661.580.58
EPS (Diluted)1.501.401.631.570.57
Weighted Avg Shares7.5M7.55M8.24M9.19M9.33M
Weighted Avg Shares (Diluted)7.59M7.65M8.35M9.25M9.33M

Transcat, Inc.

NASDAQ:TRNS

Intrinsic Alpha fair value

Locked

Current Price

$100.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.